Andrographolide: A Herbal-Chemosynthetic Approach for Enhancing Immunity, Combating Viral Infections, and Its Implication on Human Health

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2021 Nov 27

PMID 34834128

Citations 8

Authors

Archana Mishra

Haq Abdul Shaik

Rakesh Kumar Sinha

Bakht Ramin Shah

Affiliations

Soon will be listed here.

Abstract

Plants consistently synthesize and accumulate medically valuable secondary metabolites which can be isolated and clinically tested under in vitro conditions. An advancement with such important phytochemical production has been recognized and utilized as herbal drugs. Bioactive andrographolide (AGL; CHO) isolated from (AP) (Kalmegh) is a diterpenoid lactones having multifunctional medicinal properties including anti-manic, anti-inflammatory, liver, and lung protective. AGL is known for its immunostimulant activity against a variety of microbial infections thereby, regulating classical and alternative macrophage activation, Ag-specific antibody production during immune disorder therapy. In vitro studies with AGL found it to be effective against multiple tumors, neuronal disorders, diabetes, pneumonia, fibrosis, and other diverse therapeutic misadventures. Generally, virus-based diseases like ZIKA, influenza A virus subtype (H1NI), Ebola (EBOV), Dengue (DENV), and coronavirus (COVID-19) epidemics have greatly increased scientific interest and demands to develop more effective and economical immunomodulating drugs with minimal side effects. Trials and in vitro pharmacological studies with AGL and medicinally beneficial herbs might contribute to benefit the human population without using chemical-based synthetic drugs. In this review, we have discussed the possible role of AGL as a promising herbal-chemo remedy during human diseases, viral infections and as an immunity booster.

Citing Articles

Andrographolide Sulfonates and Xiyanping: A Review of Chemical Composition, Pharmacological Activities, Clinical Applications, and Adverse Reactions.

Li Z, Yao L, Liu Z, Wang L, Ruan H, Shen Y Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40005997 PMC: 11859262. DOI: 10.3390/ph18020183.

Recuperative potential of Indian medicinal plant compounds- a tool to encumber henipaviruses: an in -silico study.

Enmozhi S, Xavier I, Raaj T, Sarveswaran R, Blessings J, Kesavamoorthy Y In Silico Pharmacol. 2024; 12(2):72.

PMID: 39099797 PMC: 11294312. DOI: 10.1007/s40203-024-00236-x.

In silico network pharmacology study on Glycyrrhiza glabra: Analyzing the immune-boosting phytochemical properties of Siddha medicinal plant against COVID-19.

Sekaran K, Karthik A, Varghese R, Sathiyarajeswaran P, Shree Devi M, Siva R Adv Protein Chem Struct Biol. 2024; 138:233-255.

PMID: 38220426 PMC: 10275734. DOI: 10.1016/bs.apcsb.2023.04.003.

The role and mechanism of TCM in the prevention and treatment of infectious diseases.

Zou Q, Chen Y, Qin H, Tang R, Han T, Guo Z Front Microbiol. 2023; 14:1286364.

PMID: 38033575 PMC: 10682724. DOI: 10.3389/fmicb.2023.1286364.

Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents.

Gabbianelli R, Shahar E, de Simone G, Rucci C, Bordoni L, Feliziani G Nutrients. 2023; 15(22).

PMID: 38004113 PMC: 10675658. DOI: 10.3390/nu15224719.

References

Gherardelli C, Cisternas P, Gutierrez J, Martinez M, Inestrosa N . Andrographolide restores glucose uptake in rat hippocampal neurons. J Neurochem. 2020; 157(4):1222-1233. DOI: 10.1111/jnc.15229. View

Murugan N, Pandian C, Jeyakanthan J . Computational investigation on phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials. J Biomol Struct Dyn. 2020; 39(12):4415-4426. PMC: 7309306. DOI: 10.1080/07391102.2020.1777901. View

Alazmi M, Motwalli O . Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates. J Mol Model. 2020; 26(12):338. PMC: 7657070. DOI: 10.1007/s00894-020-04599-8. View

Shivali G, Praful L, Vijay G . A validated Fourier transform infrared spectroscopy method for quantification of total lactones in Inula racemosa and Andrographis paniculata. Phytochem Anal. 2011; 23(2):171-6. DOI: 10.1002/pca.1339. View

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F . Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7):802-810. PMC: 7097841. DOI: 10.1001/jamacardio.2020.0950. View

Wang D, Guo H, Chang J, Wang D, Liu B, Gao P . Andrographolide Prevents EV-D68 Replication by Inhibiting the Acidification of Virus-Containing Endocytic Vesicles. Front Microbiol. 2018; 9:2407. PMC: 6186950. DOI: 10.3389/fmicb.2018.02407. View

Iruretagoyena M, Tobar J, Gonzalez P, Sepulveda S, Figueroa C, Burgos R . Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. J Pharmacol Exp Ther. 2004; 312(1):366-72. DOI: 10.1124/jpet.104.072512. View

Ramalingam S, Karupannan S, Padmanaban P, Vijayan S, Sheriff K, Palani G . Anti-dengue activity of extracts and quantification of dengue viral inhibition by SYBR green reverse transcription polymerase chain reaction. Ayu. 2019; 39(2):87-91. PMC: 6369606. DOI: 10.4103/ayu.AYU_144_17. View

Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y . Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020; 10(5):766-788. PMC: 7102550. DOI: 10.1016/j.apsb.2020.02.008. View

10.

Edwin E, Vasantha-Srinivasan P, Senthil-Nathan S, Thanigaivel A, Ponsankar A, Pradeepa V . Anti-dengue efficacy of bioactive andrographolide from Andrographis paniculata (Lamiales: Acanthaceae) against the primary dengue vector Aedes aegypti (Diptera: Culicidae). Acta Trop. 2016; 163:167-78. DOI: 10.1016/j.actatropica.2016.07.009. View

11.

Sanati P, Chua L, Nasiri R, Hashemi S . Nanoencapsulation of Andrographolide Rich Extract for the Inhibition of Cervical and Neuroblastoma Cancer Cells. J Biomed Nanotechnol. 2021; 16(9):1370-1380. DOI: 10.1166/jbn.2020.2973. View

12.

Chen P, Zeng Z, Du H . Establishment and validation of a drug-target microarray for SARS-CoV-2. Biochem Biophys Res Commun. 2020; 530(1):4-9. PMC: 7373225. DOI: 10.1016/j.bbrc.2020.05.217. View

13.

Kaushik S, Dar L, Kaushik S, Yadav J . Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches. J Ethnopharmacol. 2020; 267:113541. DOI: 10.1016/j.jep.2020.113541. View

14.

Gasparotto Junior A, Tolouei S, Livero F, Gasparotto F, Boeing T, de Souza P . Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections. Curr Pharm Des. 2021; 27(13):1588-1596. DOI: 10.2174/1381612827666210114150607. View

15.

Li F, Lee E, Sun X, Wang D, Tang H, Zhou G . Design, synthesis and discovery of andrographolide derivatives against Zika virus infection. Eur J Med Chem. 2019; 187:111925. PMC: 6980694. DOI: 10.1016/j.ejmech.2019.111925. View

16.

Enmozhi S, Raja K, Sebastine I, Joseph J . Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J Biomol Struct Dyn. 2020; 39(9):3092-3098. PMC: 7212536. DOI: 10.1080/07391102.2020.1760136. View

17.

Rajagopal K, Varakumar P, Baliwada A, Byran G . Activity of phytochemical constituents of (turmeric) and against coronavirus (COVID-19): an in silico approach. Futur J Pharm Sci. 2020; 6(1):104. PMC: 7562761. DOI: 10.1186/s43094-020-00126-x. View

18.

Banerjee S, Kar A, Mukherjee P, Haldar P, Sharma N, Katiyar C . Immunoprotective potential of Ayurvedic herb Kalmegh (Andrographis paniculata) against respiratory viral infections - LC-MS/MS and network pharmacology analysis. Phytochem Anal. 2020; 32(4):629-639. DOI: 10.1002/pca.3011. View

19.

Nugraha R, Ridwansyah H, Ghozali M, Khairani A, Atik N . Traditional Herbal Medicine Candidates as Complementary Treatments for COVID-19: A Review of Their Mechanisms, Pros and Cons. Evid Based Complement Alternat Med. 2020; 2020:2560645. PMC: 7569437. DOI: 10.1155/2020/2560645. View

20.

Cubuk H, Ozbil M . Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study. Turk J Chem. 2021; 45(1):35-41. PMC: 7925319. DOI: 10.3906/kim-2008-35. View